PML with dimethyl fumarate-No convincing case against natalizumab

Martin Diebold1, Valerian Altersberger1, Bernhard F Décard1

  • 1Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|August 23, 2019
PubMed
Abstract

No abstract available in PubMed .